People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Healthtech, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Acutus Medical, Inc. | — | Healthtech | Series D+ | $296.3M | $69.0M | 2012 |
| Agenus Inc | — | Biotechnology | Series C | $211.2M | $1.2B | 2015 |
| Moximed, Inc | — | Other Health Care | Series C | $187.8M | $499.6M | 2024 |
| Aravive, Inc. | — | Biotechnology | Series C | $156.1M | $702.9M | 2011 |
Shahzad Malik at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shahzad Malik on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Johnson | 2 | 12 |
| Christopher Gleason | 1 | 35 |
| Ryan Drant | 1 | 24 |
| John Nehra | 1 | 11 |
| Srinivas Akkaraju | 1 | 10 |
| Joshua Makower | 1 | 10 |
| Steven Hochberg | 1 | 9 |
| Anthony Sun | 1 | 8 |
| Scott Huennekens | 1 | 7 |
| Timothy Wright | 1 | 7 |
| Andrew ElBardissi | 1 | 7 |
| Robert W. Croce | 1 | 7 |
| Henry A. Plain, Jr. | 1 | 7 |
| Robert K. Anderson | 1 | 6 |
| Robert Stein | 1 | 6 |
| David Bonita | 1 | 6 |
| HENRY A. PLAIN | 1 | 5 |
| Robert B. Stein | 1 | 5 |
| MICHAEL DYBBS | 1 | 5 |
| David Amerson | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.